Table 1 |
|
|
Features of TSE diseases for which the RuNAway model may provide an explanation |
|
| TSE Feature |
Explanation afforded by RuNAway |
|
|
|
| Endogenous origin of TSE |
SINEs are endogenous |
| TSE Agent becomes infectious |
TSE causing SINE is mutated for enhanced replication |
| and virulence |
|
| Long latency |
RT-mediated SINE gene proliferation is a slow |
| process. Spreading between cells is much less efficient |
|
| than viral infection |
|
| Shorter visible disease period |
Transition to aggressive second RuNAway cycle |
| Inheritance of TSE strain |
SINEs are nucleic acid and obey the laws of genetics |
| variation |
and inheritance |
| Species barrier to infection |
Adaptation to new RNA primer sequence required in |
| new host species |
|
| Absence of immune reaction |
SINEs are nucleic acid and therefore not immunogenic |
| PrP protein required for |
When overproduced, PrP protein is prone to form |
| pathology |
aggregates which damage neighbouring cells |
| Agent causes PrPSc precipitation |
SINEs can inhibit PKR a negative regulator of |
| translation, leading to overproduction of PrP protein |
|
| and deposition of amyloid plaques |
|
| PrP0/0 mouse does not succumb |
PrP0/0 mouse is infected by scrapie SINEs but without |
| to scrapie |
PrP expression no amyloid plaques can form |
| PrP0/0 mouse transmits scrapie |
TSE SINE replicates in PrP0/0 mouse cells |
| agent |
|
| PrP0/0 mouse transmits scrapie |
TSE SINE replication is dependent on SINE RNA |
| agent less efficiently than |
synthesis which is not stress-induced in the absence of |
| wildtype mouse |
second RuNAway cycle |
|
|
|
|
Gibson Genome Biology 2001 2:preprint0006.1 doi:10.1186/gb-2001-2-7-preprint0006 |
|